Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs
Clinical trial NCT02449031 · COMPLETED
Trial details
- NCT number
- NCT02449031
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-05-05
- Primary completion
- 2021-12-31
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.